Efficacy and Safety of SPARC0912 and Reference0912 in Open Angle Glaucoma or Ocular Hypertension
Status:
Completed
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
A single-blind , 12-week, parallel group clinical study is planned to evaluate the efficacy
and safety of SPARC0912 and Reference0912. SPARC0912 is an experimental drug having similar
active ingredient but containing a different preservative as that in Reference0912. Patients
with open angle glaucoma or ocular hypertension will be enrolled and randomly assigned to
receive either product. One drop will be instilled to the study eye nightly at 8:00 PM.